Uncategorized

Salesforce Inc. (NYSE:CRM) is moving beyond early Agentforce adoption as investors turn their attention to consumption, monetization and revenue growth, according to JPMorgan.Analyst Samik Chatterjee said Wednesday that Salesforce’s post-earnings product webinar strengthened the firm’s confidence in the company’s artificial…

Shares of Moderna Inc (NASDAQ:MRNA) are trading lower Wednesday morning, taking a breather following a 170% surge over the trailing month. Traders are balancing the biotech giant’s clinical breakthroughs and newly closed multi-billion-dollar financing against broader macroeconomic headwinds and elevated…

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) on Wednesday announced the publication of 96-week Phase 3 trial data evaluating its gene therapy GENGLYCOS, also known as DTX401, for patients with glycogen storage disease type Ia (GSDIa). Published in The Journal of Inherited Metabolic…

U.S. stocks were mostly higher, with the Dow Jones index gaining around 250 points on Wednesday. Shares of Sirius XM Holdings Inc (NASDAQ:SIRI) rose sharply during Wednesday’s session after Deutsche Bank upgraded the stock from Hold to Buy and raised…

OpenAI CEO Sam Altman is sounding an alarm on the AI infrastructure boom — and traders in neocloud names like CoreWeave (NASDAQ:CRWV), Nebius Group (NASDAQ:NBIS) and IREN Ltd. (NASDAQ:IREN) are taking notice. CRWV stock is moving. See the real-time price…

Chevron Corporation (NYSE:CVX) on Wednesday disclosed new agreements with Venezuela that revise the terms of its joint ventures, paving the way for additional investment, project development and production growth. This follows recent news of President Donald Trump allowing U.S. companies…

Shares of bioAffinity Technologies Inc. (NASDAQ:BIAF) are surging Wednesday morning as traders digest recent commercial expansion announcements alongside tight low-float trading dynamics. The micro-cap biotechnology stock has seen sharp price swings following the company’s disclosure broadening the commercial application of…

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) on Wednesday reported encouraging topline outcomes from an active Phase 2a clinical trial evaluating TEV ‘408, an experimental anti-interleukin-15 monoclonal antibody, for celiac disease. Coeliac disease is a chronic autoimmune condition where eating gluten damages…

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) shares are trading higher after the company announced positive topline results from an ongoing Phase 2a study of TEV ‘408. The study met its primary endpoint. Teva stock is trading at elevated levels. Where are TEVA…

Shares of GameStop Corp. (NYSE:GME) are trading modestly higher Wednesday morning. Investors continue to process the company’s preliminary second-quarter financial update released on August 31. The stock is finding a floor ahead of its official earnings presentation scheduled for September…